Listen to episode 69
Episode summary
Varun Turlapati explores how investors can distinguish compelling MedTech pitches from credible products. The discussion emphasizes checking scientific foundations, clinical usefulness, regulatory fit, reimbursement assumptions, and engineering readiness before treating an attractive story as a sound investment.
Key points
- Testing scientific credibility
- Assessing real clinical demand
- Regulatory and reimbursement diligence